silybin has been researched along with Astrocytoma, Grade IV in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Caccese, M; Cecchin, D; Cerretti, G; Denaro, L; Lombardi, G; Padovan, M; Zagonel, V | 1 |
| Appel, D; Gülden, M; Seibert, H; Syska, M; Uecker, S; Wages, F | 1 |
| Bai, ZL; Guo, SZ; Ren, J; Shu, MG; Tay, V | 1 |
| Chakrabarti, M; Ray, SK | 2 |
| Rivera-Delgado, E; von Recum, HA | 1 |
| Emami, AH; Ghadimi, H; Ghaffari, SH; Ghasemi, R; Ghavamzadeh, A; Malehmir, M; Momeny, M; Nafissi, S; Shokrgozar, MA; Zakidizaji, M | 1 |
| Alimoghaddam, K; Dizaji, MZ; Ghaffari, SH; Ghavamzadeh, A; Malehmir, M | 1 |
8 other study(ies) available for silybin and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E -mutant and SOX2 amplification.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Glioblastoma; Humans; Male; Mutation; Prospective Studies; Proto-Oncogene Proteins B-raf; Pyridones; Silybin; SOXB1 Transcription Factors | 2023 |
Chrysin and silibinin sensitize human glioblastoma cells for arsenic trioxide.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; ATP-Binding Cassette Transporters; Cell Line, Tumor; Flavonoids; Glioblastoma; Humans; Oxides; Silybin; Silymarin | 2017 |
Silibinin Induced Human Glioblastoma Cell Apoptosis Concomitant with Autophagy through Simultaneous Inhibition of mTOR and YAP.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Autophagy; Cell Line, Tumor; Glioblastoma; Humans; Phosphoproteins; Silybin; Silymarin; TOR Serine-Threonine Kinases; Transcription Factors; YAP-Signaling Proteins | 2018 |
Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Glioblastoma; Humans; Luteolin; Neoplasm Invasiveness; Neoplastic Stem Cells; Silybin; Silymarin | 2015 |
Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Brain Neoplasms; Carmustine; Caspase 8; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dacarbazine; Female; Glioblastoma; Humans; Luteolin; Mice; Mice, Nude; MicroRNAs; Signal Transduction; Silybin; Silymarin; Sirolimus; Temozolomide; Xenograft Model Antitumor Assays | 2016 |
Using Affinity To Provide Long-Term Delivery of Antiangiogenic Drugs in Cancer Therapy.
Topics: 2-Methoxyestradiol; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cellulose; Cyclodextrins; Drug Delivery Systems; Estradiol; Female; Glioblastoma; Humans; Indoles; Mice; Mice, Nude; ortho-Aminobenzoates; Pyrroles; Silybin; Silymarin | 2017 |
Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix metalloproteinase 9.
Topics: Antineoplastic Agents; Cathepsin B; Cell Line, Tumor; Cell Proliferation; Cystatin A; Glioblastoma; Humans; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase Inhibitors; NF-kappa B; Receptors, Urokinase Plasminogen Activator; Silybin; Silymarin | 2010 |
Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Cell Line, Tumor; Drug Synergism; Glioblastoma; Humans; Neoplasm Invasiveness; Oxides; Silybin; Silymarin | 2012 |